Eduardo Mysler, MD

Eduardo Mysler, MD

Executive medical director, Organización Medica de Investigación, Argentina

Articles by Eduardo Mysler, MD

Switch, Don’t Cycle: Upadacitinib Outperforms Adalimumab in RA Post-TNFi, With Eduardo Mysler, MD

Switch, Don’t Cycle: Upadacitinib Outperforms Adalimumab in RA Post-TNFi, With Eduardo Mysler, MD

ByEduardo Mysler, MD

October 24th 2025

Mysler emphasized the first definitive evidence informing sequencing after failing a first TNF inhibitor.

Latest Updated Articles

Switch, Don’t Cycle: Upadacitinib Outperforms Adalimumab in RA Post-TNFi, With Eduardo Mysler, MD
Published: October 24th 2025 | Updated: